- Sections
- C - Chimie; métallurgie
- C07H - Sucres; leurs dérivés; nucléosides; nucléotides; acides nucléiques
- C07H 15/20 - Carbocycles
Détention brevets de la classe C07H 15/20
Brevets de cette classe: 131
Historique des publications depuis 10 ans
7
|
8
|
10
|
4
|
8
|
11
|
2
|
5
|
4
|
1
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
Proprétaire |
Total
|
Cette classe
|
---|---|---|
Cipla USA, Inc. | 28 |
5 |
Glycosynth Limited | 5 |
4 |
Centre National de La Recherche Scientifique | 10052 |
3 |
Vertex Pharmaceuticals Incorporated | 1570 |
3 |
The Coca-Cola Company | 2509 |
3 |
Infectious Disease Research Institute | 45 |
3 |
The University of British Columbia | 1464 |
3 |
CHDI Foundation, Inc. | 108 |
2 |
The Governors of the University of Alberta | 882 |
2 |
Her Majesty The Queen in Right of Canada, AS represented by The Minister of Agriculture and Agri-food | 96 |
2 |
Ionis Pharmaceuticals, Inc. | 839 |
2 |
PureCircle Sdn Bhd | 226 |
2 |
Shenzhen Neptunus Pharmaceutical Holdings Co., Ltd. | 3 |
2 |
TriAct Therapeutics, Inc. | 13 |
2 |
Unigen, Inc. | 20 |
2 |
Unigen, Inc. | 116 |
2 |
University of Georgia Research Foundation, Inc. | 1000 |
2 |
University of Washington through its Center for Commercialization | 506 |
2 |
Washington University | 1535 |
2 |
Glycoscience, S.L. | 16 |
2 |
Autres propriétaires | 81 |